Clopidogrel

Product NDC: 55648-315
11-digit product format: 556480315
Labeler code: 55648
Product ID: 55648-315_79a0b285-80de-4b38-9d3f-37fb165ef36b
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Clopidogrel
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Wockhardt Limited
Application: ANDA202266
Marketing category: ANDA
Marketing start: 2012-11-13
Marketing end: 0000-00-00
Substance: CLOPIDOGREL BISULFATE
Active strength: 300 mg/1
Pharmacologic classes: Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	55648-315		I	Inactivated by FDA	2026-08-07
excluded package	package	55648-315	55648-315-00	I	Inactivated by FDA	2026-08-07
excluded package	package	55648-315	55648-315-01	I	Inactivated by FDA	2026-08-07
excluded package	package	55648-315	55648-315-02	I	Inactivated by FDA	2026-08-07
excluded package	package	55648-315	55648-315-04	I	Inactivated by FDA	2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 110 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	55648-315-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	55648-315-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	55648-315-04	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	55648-315-00	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	55648-315-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	55648-315-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	55648-315-04	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	55648-315-00	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55648-315-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55648-315-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55648-315-04	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55648-315-00	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55648-315-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55648-315-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55648-315-04	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55648-315-00	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55648-315-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55648-315-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55648-315-04	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55648-315-00	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55648-315-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55648-315-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55648-315-04	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55648-315-00	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55648-315-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55648-315-02	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55648-315-04	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55648-315-00	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55648-315-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55648-315-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55648-315-04	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55648-315-00	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	55648-315-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	55648-315-02	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	55648-315-04	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	55648-315-00	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	55648-315-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	55648-315-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	55648-315-04	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	55648-315-00	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	55648-315-01	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	55648-315-02	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	55648-315-04	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	55648-315-00	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	55648-315-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	55648-315-02	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	55648-315-04	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	55648-315-00	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A202266-001	CLOPIDOGREL BISULFATE	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL			2012-08-14
A202266-002	CLOPIDOGREL BISULFATE	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL			2012-11-20

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL	AB	2012-08-14	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL	AB	2012-11-20	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A202266-001	CLOPIDOGREL BISULFATE	EQ 75MG BASE	TABLET / ORAL		2012-08-14	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A202266-002	CLOPIDOGREL BISULFATE	EQ 300MG BASE	TABLET / ORAL		2012-11-20	`782e0a99824c…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A202266-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A202266-002	AB	1	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	A202266-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A202266-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A202266-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A202266-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A202266-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A202266-002	AB	1	`ea99ee380514…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
39fa80eb-1490-ce82-3d3a-820ae7c37b85	Product name	5	20250618

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
55648-315-00	These highlights do not include all the information needed to use clopidogrel safely and effectively. See full prescribing information for clopidogrel. Clopidogrel Tablets, USP Initial U.S. Approval: 1997
55648-315-01	These highlights do not include all the information needed to use clopidogrel safely and effectively. See full prescribing information for clopidogrel. Clopidogrel Tablets, USP Initial U.S. Approval: 1997
55648-315-02	These highlights do not include all the information needed to use clopidogrel safely and effectively. See full prescribing information for clopidogrel. Clopidogrel Tablets, USP Initial U.S. Approval: 1997
55648-315-04	These highlights do not include all the information needed to use clopidogrel safely and effectively. See full prescribing information for clopidogrel. Clopidogrel Tablets, USP Initial U.S. Approval: 1997

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
55648-315-00	Clopidogrel	1500 in 1 POUCH	TABLET, FILM COATED	1500	2
55648-315-01	Clopidogrel	30 in 1 BOTTLE	TABLET, FILM COATED	30	2
55648-315-02	Clopidogrel	90 in 1 BOTTLE	TABLET, FILM COATED	90	2
55648-315-04	Clopidogrel	10 in 1 CARTON	TABLET, FILM COATED	10	2
55648-315-04	Clopidogrel	10 in 1 BLISTER PACK	TABLET, FILM COATED	10	2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CLOPIDOGREL BISULFATE	ACTIVE INGREDIENT	08I79HTP27	CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT LIMITED]	2
CLOPIDOGREL	ACTIVE MOIETY	A74586SNO7	CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT LIMITED]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT LIMITED]	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT LIMITED]	2
GLYCERYL DIBEHENATE	INACTIVE INGREDIENT	R8WTH25YS2	CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT LIMITED]	2
HYDROGENATED CASTOR OIL	INACTIVE INGREDIENT	ZF94AP8MEY	CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT LIMITED]	2
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT LIMITED]	2
HYPROMELLOSE 2910 (15 MPA.S)	INACTIVE INGREDIENT	36SFW2JZ0W	CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT LIMITED]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT LIMITED]	2
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT LIMITED]	2
POLYETHYLENE GLYCOL 6000	INACTIVE INGREDIENT	30IQX730WE	CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT LIMITED]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT LIMITED]	2
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT LIMITED]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
55648-315	CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT LIMITED]	2	Legacy NDC, 5 package rows	20121113_de099108-7445-4632-b85f-93a1bc05adf0.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
08I79HTP27	CLOPIDOGREL BISULFATE	120202-66-6	CLOPIDOGREL BISULFATE
A74586SNO7	CLOPIDOGREL	113665-84-2	Clopidogrel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
749196	clopidogrel 300 MG Oral Tablet	PSN	de099108-7445-4632-b85f-93a1bc05adf0	2
309362	clopidogrel 75 MG Oral Tablet	PSN	de099108-7445-4632-b85f-93a1bc05adf0	2
749196	clopidogrel 300 MG Oral Tablet	SCD	de099108-7445-4632-b85f-93a1bc05adf0	2
309362	clopidogrel 75 MG Oral Tablet	SCD	de099108-7445-4632-b85f-93a1bc05adf0	2
749196	clopidogrel 300 MG (as clopidogrel bisulfate 391.5 MG) Oral Tablet	SY	de099108-7445-4632-b85f-93a1bc05adf0	2
309362	clopidogrel 75 MG (as clopidogrel bisulfate 97.875 MG) Oral Tablet	SY	de099108-7445-4632-b85f-93a1bc05adf0	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
55648-315-00	55648031500	1500 in 1 POUCH	Historical
55648-315-01	55648031501	30 in 1 BOTTLE	Historical
55648-315-02	55648031502	90 in 1 BOTTLE	Historical
55648-315-04	55648031504	10 in 1 CARTON	Historical